Sign in
Taking peoplePhase 3

Pooled Human Plasma vs Crystalloid in The Management of Children Undergoing Instrumented Spinal Fusion for Scoliosis

Key facts

Who runs it
Turku University Hospital
Where
Finland2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
Phase
Phase 3
People taking part
194 people, planned
Started
2 May 2025
Expected to end
31 Dec 2030
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Pooled human plasma
  • Placebo
Record updated
7 May 2025

Who can take part

Age
10 years to 21 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 29 criteriaShow less

Who can take part

  • Written informed consent
  • Aged between 10 and 21 years of age
  • Scoliosis requiring posterior scoliosis surgery using all pedicle screw technique for AIS (>45-degree major curve) or NMS (>50-degree major curve)
  • Normal whole spine MRI except for the spinal deformity (only for patients with adolescent idiopathic scoliosis as patients with neuromuscular scoliosis do not typically undergo MR images as they would need general anaesthesia)

Who cannot take part

  • Need for anteroposterior surgery
  • Need for three column vertebral resection
  • Participation in another study and receipt of any other investigational agent during 2 year period of current investigation
  • Known history of, or documented positive hepatitis B or C or HIV infection Prior or concurrent malignancy
  • Amiodarone medication
  • Diabetes mellitus
  • Allergy or hypersensitivity to study medications or their ingredients
  • Any significant disease or disorder which, in the opinion of the investigator, may either put the subject at risk by participation in the study, or may influence the result of the study
  • A history of drug or alcohol use that, in the opinion of the investigator, would interfere with adherence to study requirements
  • Renal insufficiency
  • Hypersensitivity for active component or additives
  • Aspartate transaminase (AST) or alanine transaminase (ALT) ≥ 3 x upper-limit of normal
  • Creatinine clearance (CrCl) < 60 ml/min measured by 24-hour urine collection or estimated from the Cockcroft and Gault formula
  • Immunoglobulin A-deficiency
  • Smoking
  • Abnormalities in blood coagulation (thromboplastin time below above or below of normal values, 70-130%)
  • Blood trombosytes less than 150 x E9/l
  • Body mass index over 40
  • Pregnancy or breast-feeding, aim of becoming pregnant during the study
  • Inability to provide written informed consent
  • Clinically significant ECG findings as judged by the investigator
  • Hyperkalemia
  • AV-block
  • Metabolic or respiratory alkalosis
  • Hypochlorhydria

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 10 and 21 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

OCTAGON trial is a randomized, double-blinded, parallel-group non-inferiority multicenter (Helsinki and Turku University Hospitals, Finland) clinical trial according to CONSORT criteria.

Read full original descriptionShow less

194 adolescents with idiopathic (major curve > 45 degrees) or neuromuscular scoliosis (major curve > 50 degrees) are enrolled for the OCTAGON trial comparing pooled human plasma (Octaplas, 10mL/kg, active management) vs. Plasmalyte (10 mL/kg, placebo) before incision as part of the normal intraoperative fluid therapy. Data is collected at baseline and at each follow-up until a minimum of 2-year follow-up.

Outcomes Outcomes for the OCTAGON trial include 1) intraoperative blood loss (in mL, primary outcome) and the need for allogenic red blood cell infusion (percentage of patients). Secondary outcomes include health-related quality of life (Scoliosis Research Society 24 outcome questionnaire), postoperative pain (48-hour opioid consumption), operative time (hours), drain output (mL), hidden blood loss (mL), hospital stay, and complications (skin reactions, TRALI, deep surgical site infection, neurologic deficit).

Research questions and hypothesis Does prophylactic use of pooled human plasma decrease intraoperative blood loss in adolescents undergoing instrumented spinal fusion for scoliosis? We hypothesize that pooled human plasma will reduce intraoperative and total blood loss by 25% resulting in lower need for blood transfusion and fewer surgical site infections.

Objectives To compare the effect of pooled human plasma vs. crystalloid fluids on intraoperative bleeding and total blood loss (drain output and hidden blood loss) in children undergoing posterior spinal fusion for AIS and NMS. Adverse events will be recorded and reported as minor (skin reaction) or major (severe allergic reaction, transfusion related acute lung injury, TRALI, deep surgical site infection, neurologic injury).

Ethical aspects The PHP trial has been evaluated via European regulatory authority (EU CT: 2024-514857-31-00) and by Fimea (FIMEA/2024/006588). Informed consent is obtained from the parent(s). Results will be disseminated in high-quality peer-reviewed publications.

The individual patient safety and high-quality management of fractures and scoliosis is a priority in this trial. The randomization can be opened at any stage of the treatment process. Based on the clinical decision the randomized treatment can be terminated and treatment provided accord-ing to clinical decision making even if results will be evaluated using the intention to treat princi-ple. Pain management will be prioritized in every clinical scenario and parental presence is always possible.

The 2 groups in the trial

  • Pooled human plasmaExisting treatment, for comparison

    Pooled human plasma (Octaplas, 10mL/kg, max 400 mL)

  • PlaceboPlacebo, for comparison

    Crystalloid infusion (Plasmalyte, 10 mL/kg, max 400 mL)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Pooled Human Plasma vs Crystalloid in The Management of Children Undergoing Instrumented Spinal Fusion for Scoliosis: A Double-Blind, Randomized Clinical Trial
Criteria questions
Built from NCT06934278, who can take part
Record updated
7 May 2025